National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (May Update) Instrument 2021 (Cth)
PB 42 of 2021
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (May Update) Instrument 2021
National Health Act 1953
___________________________________________________________________________
I, BEN SLADIC, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Amendment Instrument under subsection 100(2) of the National Health Act 1953.
Dated 28 April 2021
BEN SLADIC
Assistant Secretary
Pharmacy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
Name of Instrument
(1)This Instrument is the National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (May Update) Instrument 2021.
(2)This Instrument may also be cited as PB 42 of 2021.
Commencement
This Instrument commences on 1 May 2021.
Amendment of National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021)
Schedule 1 amends the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021).
Schedule 1 Amendments
Schedule 1, entry for Tenofovir with emtricitabine in the form Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg
insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
| CIPLA TENOFOVIR + EMTRICITABINE 300/200 | C6985 C6986 | 60 | 5 |
0
0
0